Gastroenteropancreatic high-grade neuroendocrine carcinoma - Test2 - elhamkhani - TriplyDB

Gastroenteropancreatic high-grade neuroendocrine carcinoma

Gastroenteropancreatic high-grade neuroendocrine carcinoma

http://www.wikidata.org/entity/Q26998392

about

Medical treatment for gastro-entero-pancreatic neuroendocrine tumours Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy.Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.Irinotecan plus cisplatin followed by octreotide long-acting release maintenance treatment in advanced gastroenteropancreatic neuroendocrine carcinoma: IPO-NEC study.Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma.Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.High-Grade Neuroendocrine Colorectal Carcinomas: A Retrospective Study of 100 Patients Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.A Case of Poorly Differentiated Large-Cell Neuroendocrine Carcinoma of the Cecum: A Rare Malignancy, with Review of the Literature.Prognostic factors in neuroendocrine carcinoma: biological markers are more useful than histomorphological markers.Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.The prognostic influence of the proliferative discordance in metastatic pancreatic neuroendocrine carcinoma revealed by peptide receptor radionuclide therapy: Case report and review of literature Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading.Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas.Pathology and Surgical Treatment of High-Grade Pancreatic Neuroendocrine Carcinoma: an Evolving Landscape.An Overview on the Sequential Treatment of Pancreatic Neuroendocrine Tumors (pNETs).A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study.Comparison of Three Ki-67 Index Quantification Methods and Clinical Significance in Pancreatic Neuroendocrine Tumors.Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study.Amrubicin Monotherapy for Patients with Platinum-Refractory Gastroenteropancreatic Neuroendocrine Carcinoma.Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas.Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma.Risk factors associated with the progression and metastases of hindgut neuroendocrine tumors: a retrospective study.Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy.Prognoses in patients with primary gastrointestinal neuroendocrine neoplasms based on the proposed new classification scheme.Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases.Gastroenteropancreatic-origin neuroendocrine carcinomas: Three case reports with favorable responses following localized radiotherapy and a review of literature.Chemotherapy in NETs: When and how.Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20.Frequent BRAF mutations suggest a novel oncogenic driver in colonic neuroendocrine carcinoma.Primary high-grade neuroendocrine carcinoma emerging from an adenomatous polyp in the setting of familial adenomatous polyposis.Neuroendocrine Neoplasms: Dichotomy, Origin and Classifications.Expression of PD-1 and PD-L1 in poorly differentiated neuroendocrine carcinomas of the digestive system: a potential target for anti-PD-1/PD-L1 therapy.Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology.

P2860

Q26751659-4990F460-473D-4F87-A863-3C191F66F5CD Q26768483-A2DDB7BF-28DD-4A5C-AFA7-73B7D59A8236 Q27853371-FBE39DAB-41E6-4300-BBE6-B7256D3E138D Q28078501-59766F72-A7C5-459A-9226-D37DE7E4C552 Q30249051-182234E1-10F7-4C7F-85D2-F691E52E5E66 Q33648996-93576F9E-AD12-4677-89E9-1DF1395E191A Q36153131-BFBBC477-73E3-4E40-84EE-98F6BB7CD9F5 Q36352317-8F9CEBA4-33F4-4658-92C7-26B18621E4B7 Q36687213-77E7C9AE-D367-4A1D-85E7-76D7C4B14D31 Q36948373-CE9E89A1-B162-4B11-8380-F9935BC4651F Q37182620-E2A2F554-06A2-4E6E-BA04-79A12A0F4C9B Q37562989-15BB5C7D-86A5-427E-B647-2F8D9EA52529 Q37578830-6CAEB03D-0D27-40D0-A28F-EBEF9F138EAA Q37624511-98932AA6-4AEC-45F4-B680-18A2F860ECD0 Q37629658-60B9C72F-88E6-4633-873E-A95E4F293F22 Q37631597-FEF8BD28-D5E1-4A36-9955-5E8DDE2AE3E4 Q37646677-4B2B28F2-8A03-4DA9-AD77-DA1406DAF144 Q38610333-B9C19E20-405A-45CF-B982-044C720A6BA2 Q38764884-D4EF53EC-F318-4242-B79C-903F5BBF2B9A Q38777613-E0B57D56-496F-40F4-9502-0F8340C63198 Q38835123-3B12B495-3D39-4B7D-80EA-039A948C0A1F Q38853033-EF1224C7-B50D-4AD0-BBDB-D83FE6086DEF Q40200855-326CEE11-7448-46D2-9346-761684CBF99B Q40288265-A34EF888-E9B1-4D39-A0F2-22387D1C1147 Q41198847-9CE42CF9-EE30-48F6-83D7-593FB0FE3436 Q41339782-C944D308-EB1F-4F16-91DE-918B4B88CD47 Q45071563-003F9FF6-2F04-4587-B803-E9CA524D5E73 Q46513952-E9B68880-DB1E-460B-986B-BE67EFE4316C Q47108531-FC3E1F59-B301-4E28-B5F2-DBE6CF814A55 Q47128709-5D0E292B-1437-41C9-A2FA-650F1B920483 Q47283973-4E60227E-5129-48FE-A55F-C3C2AD07658E Q47358369-42568AC5-CCE5-4A98-A3C3-5C9EDB1BB674 Q47564366-499B29C9-4D0F-411D-95DE-A4B1E4633F99 Q47692261-9B3B0E02-4A99-4DFD-9972-7F12BA44265C Q48088751-64975560-B009-4FCA-9928-A52AA9376D97 Q48306172-8F00F5CD-70C2-4394-980E-5951DAB8E4ED Q49328323-2677FBB5-FC83-4092-A77E-D904199681D5 Q49612106-9B8CF958-63A8-48FB-B5E9-324390A601A0 Q50076875-FEEB8EE1-C2AF-4AE6-8A5D-6CAD9CE141E7 Q50355400-3A08834D-64C9-4C83-AF11-9D26006B9F2F

P2860

Gastroenteropancreatic high-grade neuroendocrine carcinoma

http://www.wikidata.org/entity/Q26998392

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Gastroenteropancreatic high-grade neuroendocrine carcinoma

@ast

Gastroenteropancreatic high-grade neuroendocrine carcinoma

@en

Gastroenteropancreatic high-grade neuroendocrine carcinoma

@nl

type

label

Gastroenteropancreatic high-grade neuroendocrine carcinoma

@ast

Gastroenteropancreatic high-grade neuroendocrine carcinoma

@en

Gastroenteropancreatic high-grade neuroendocrine carcinoma

@nl

prefLabel

Gastroenteropancreatic high-grade neuroendocrine carcinoma

@ast

Gastroenteropancreatic high-grade neuroendocrine carcinoma

@en

Gastroenteropancreatic high-grade neuroendocrine carcinoma

@nl

P1433

Q26998392-10FC2D08-DB5B-4403-9453-6A64BFAEC14D

P1476

Q26998392-29E1494A-212B-46C0-A98F-1D00C13C0AFF

P2093

Q26998392-03E6A39E-BF1D-41C4-8910-8CBC2985DA3E

Q26998392-48C2F4F3-3013-423F-930C-B38E86C25006

Q26998392-73C40947-F330-4B46-A4DB-FA05A518C472

Q26998392-8867EB95-2338-436A-B9D2-E9A0E3CB3CA0

Q26998392-CA09BDDA-FA22-471B-A528-23CB4632FC29

P2860

Q26998392-04137168-71CC-45B8-9C24-F5E68F903CB1

Q26998392-0F9602DF-B110-4AE8-87B7-2768766A8515

Q26998392-10B0916B-218F-47B9-95BE-369C1EDCC102

Q26998392-18FEADA2-058C-410D-B310-85AA5F982F97

Q26998392-1F2C7390-FBF7-409A-93D7-57B3E5D5D689

Q26998392-23038DDE-5B02-4BD4-9162-F83838DC5A57

Q26998392-3926D550-1294-48DF-A865-A7752507A26A

Q26998392-39885661-CE62-4E9C-970C-46483821AC6C

Q26998392-3CAA639E-4944-4F83-BE50-93EF935F9EE4

Q26998392-3F3C2CB7-303C-4AE6-8E04-B57D44B5B6BE

P304

Q26998392-6887BFC3-25E6-47F0-BC97-EF467C6DD204

P31

Q26998392-5E3B5FE7-5307-4980-8292-83628238C603

P356

Q26998392-7DB9BBD1-23A0-4B3E-BA74-7DE5D965D03B

P407

Q26998392-BBEBBA43-7A76-4EE1-A8DB-5CEC942E5E10

P433

Q26998392-FCA6EE8D-03A2-491D-82D3-6334C26D5C6E

P478

Q26998392-2857F9FC-DF79-481B-BC44-D474BF00632B

P577

Q26998392-9B268992-A18F-41BD-87FC-0F3370371456

P5875

Q26998392-A8BB77A2-93F8-489B-8A9F-A2F681D03E61

P698

Q26998392-1AF57029-AB89-445E-BEBF-8461BA6A76CC

P356

P1433

P1476

Gastroenteropancreatic high-grade neuroendocrine carcinoma

@en

P2093

David S. Klimstra

http://www.w3.org/2001/XMLSchema#string

Eric Baudin

http://www.w3.org/2001/XMLSchema#string

Halfdan Sorbye

http://www.w3.org/2001/XMLSchema#string

James C. Yao

http://www.w3.org/2001/XMLSchema#string

Jonathan Strosberg

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.

The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970-2004

Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors

Neuroendocrine carcinomas of the colon and rectum.

Small-cell carcinomas of the gastrointestinal tract: a review.

Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.

Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study.

Rare tumors of the colon and rectum: a national review.

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin.

Small cell carcinomas of the gastrointestinal tract: clinicopathological features and treatment approach.

P304

2814-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.28721

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261958445

http://www.w3.org/2001/XMLSchema#string

P698

24771552

http://www.w3.org/2001/XMLSchema#string